Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: 2016 Supplemental Victimization Survey (SVS), 20422-20423 [2016-07961]

Download as PDF 20422 Federal Register / Vol. 81, No. 67 / Thursday, April 7, 2016 / Notices Controlled substance Schedule Phenmetrazine (1631) ................................................................................................................................................................................. Amobarbital (2125) ...................................................................................................................................................................................... Pentobarbital (2270) .................................................................................................................................................................................... Secobarbital (2315) ..................................................................................................................................................................................... Glutethimide (2550) ..................................................................................................................................................................................... Nabilone (7379) ........................................................................................................................................................................................... 1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. Phencyclidine (7471) ................................................................................................................................................................................... Phenylacetone (8501) ................................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ Alphaprodine (9010) .................................................................................................................................................................................... Anileridine (9020) ........................................................................................................................................................................................ Etorphine HCI (9059) .................................................................................................................................................................................. Dihydrocodeine (9120) ................................................................................................................................................................................ Diphenoxylate (9170) .................................................................................................................................................................................. Ecgonine (9180) .......................................................................................................................................................................................... Ethylmorphine (9190) .................................................................................................................................................................................. Levomethorphan (9210) .............................................................................................................................................................................. Levorphanol (9220) ..................................................................................................................................................................................... Isomethadone (9226) .................................................................................................................................................................................. Meperidine (9230) ....................................................................................................................................................................................... Meperidine intermediate-A (9232) ............................................................................................................................................................... Meperidine intermediate-B (9233) ............................................................................................................................................................... Meperidine intermediate-C (9234) ............................................................................................................................................................... Metazocine (9240) ....................................................................................................................................................................................... Metopon (9260) ........................................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. Dihydroetorphine (9334) .............................................................................................................................................................................. Levo-alphacetylmethadol (9648) ................................................................................................................................................................. Noroxymorphone (9668) .............................................................................................................................................................................. Phenazocine (9715) .................................................................................................................................................................................... Piminodine (9730) ....................................................................................................................................................................................... Racemethorphan (9732) .............................................................................................................................................................................. Racemorphan (9733) ................................................................................................................................................................................... Alfentanil (9737) .......................................................................................................................................................................................... Remifentanil (9739) ..................................................................................................................................................................................... Sufentanil (9740) ......................................................................................................................................................................................... Carfentanil (9743) ........................................................................................................................................................................................ Tapentadol (9780) ....................................................................................................................................................................................... Bezitramide (9800) ...................................................................................................................................................................................... Moramide-intermediate (9802) .................................................................................................................................................................... mstockstill on DSK4VPTVN1PROD with NOTICES The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: March 29, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–07947 Filed 4–6–16; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 16:35 Apr 06, 2016 Jkt 238001 FOREIGN CLAIMS SETTLEMENT COMMISSION [F.C.S.C. Meeting and Hearing Notice No. 4–16] Sunshine Act Meeting The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR part 503.25) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of open meetings as follows: Thursday, April 14, 2016 10:00 a.m.—Oral hearings on Objection to Commission’s Proposed Decision in Claim No. LIB–III–012. 11:30 a.m.—Issuance of Proposed Decisions in claims against Iraq. Status: Open. All meetings are held at the Foreign Claims Settlement Commission, 600 E Street NW., Washington, DC. Requests for information, or advance notices of intention to observe an open meeting, PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II may be directed to: Patricia M. Hall, Foreign Claims Settlement Commission, 600 E Street NW., Suite 6002, Washington, DC 20579. Telephone: (202) 616–6975. Brian M. Simkin, Chief Counsel. [FR Doc. 2016–08019 Filed 4–5–16; 8:45 am] BILLING CODE 4410–BA–P DEPARTMENT OF JUSTICE [OMB Number 1121–0302] Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: 2016 Supplemental Victimization Survey (SVS) Bureau of Justice Statistics, Department of Justice. ACTION: 30-Day notice. AGENCY: E:\FR\FM\07APN1.SGM 07APN1 Federal Register / Vol. 81, No. 67 / Thursday, April 7, 2016 / Notices The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at 81 FR 6050, February 4, 2016, allowing for a 60 day comment period. SUMMARY: Comments are encouraged and will be accepted for an additional 30 days until May 9, 2016. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Jennifer Truman or Rachel Morgan, Statisticians, Bureau of Justice Statistics, 810 Seventh Street NW., Washington, DC 20531 (email: Jennifer.Truman@ usdoj.gov; telephone: 202–514–5083; email: Rachel.Morgan@usdoj.gov; telephone: 202–616–1707). Written comments and/or suggestions can also be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20530 or sent to OIRA_ submissions@omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., mstockstill on DSK4VPTVN1PROD with NOTICES DATES: VerDate Sep<11>2014 16:35 Apr 06, 2016 Jkt 238001 permitting electronic submission of responses. Overview of this information collection: (1) Type of Information Collection: Reinstatement of the Supplemental Victimization Survey (SVS), with changes, a previously approved collection for which approval has expired. (2) Title of the Form/Collection: 2016 Supplemental Victimization Survey (SVS) (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: The form number for the questionnaire is SVS–1. The applicable component within the Department of Justice is the Bureau of Justice Statistics, in the Office of Justice Programs. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Respondents will be persons 16 years or older living in households located throughout the United States sampled for the National Crime Victimization Survey (NCVS). The SVS will be conducted as a supplement to the NCVS in all sample households for a six (6) month period. The SVS is primarily an effort to measure the prevalence of stalking victimization among persons, the types of stalking victimization experienced, the characteristics of stalking victims, the nature and consequences of stalking victimization, and patterns of reporting to the police. BJS plans to publish this information in reports and reference it when responding to queries from the U.S. Congress, Executive Office of the President, the U.S. Supreme Court, state officials, international organizations, researchers, students, the media, and others interested in criminal justices statistics. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An estimate of the total number of respondents is 111,960. About 98.5% (110,280) will have no stalking victimization and will complete the short interview with an average burden of four (4) minutes. Among the 1.5% of respondents (1,679) who experience stalking victimization, the time to ask the detailed questions regarding the aspects of their stalking victimization is estimated to take an average of 12.25 minutes. Respondents will be asked to respond to this survey only once during the six month period. The burden estimates are based on data from the prior administration of the SVS. (6) An estimate of the total public burden (in hours) associated with the PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 20423 collection: There are an estimated 8,055 total burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., 3E.405B, Washington, DC 20530. Dated: April 4, 2016. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2016–07961 Filed 4–6–16; 8:45 am] BILLING CODE 4410–18–P DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Modification of Consent Decree Under the Clean Air Act On March 30, 2016, the Department of Justice lodged a proposed stipulation to modify a Consent Decree with the United States District Court for the Eastern District of Wisconsin in the lawsuit entitled United States v. Wisconsin Public Service Corporation, Civil Case No. 13–C–10 (E.D. Wis.). The original Consent Decree resolved alleged violations of the New Source Review and Title V provisions of the Clean Air Act (‘‘Act’’), 42 U.S.C. 7470– 92 and 7661a–7661f, at two coal-fired power plants owned and operated by Wisconsin Public Service Corp (‘‘Defendant’’): the Weston plant located in Marathon County, Wisconsin, and the Pulliam plant located in Brown County, Wisconsin. The proposed modifications would: (1) Facilitate the Defendant’s decision to convert a unit at the Weston plant from burning coal to natural gas, thereby reducing particulate matter (‘‘PM’’) emissions such that the operation of certain PM controls at that unit is no longer necessary to achieve the PM reductions secured by the Decree; (2) replace a hydroelectric environmental mitigation project that was deemed unworkable with a new land acquisition and restoration project and an expansion of an existing wood stove replacement program; and (3) revise and update certain administrative notice and certification requirements. The publication of this notice opens a period for public comment on the proposed modifications to the Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States v. Wisconsin Public Service Corporation, Civil Case No. 13–C–10 E:\FR\FM\07APN1.SGM 07APN1

Agencies

[Federal Register Volume 81, Number 67 (Thursday, April 7, 2016)]
[Notices]
[Pages 20422-20423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07961]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1121-0302]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Reinstatement, With Change, of a Previously 
Approved Collection for Which Approval Has Expired: 2016 Supplemental 
Victimization Survey (SVS)

AGENCY: Bureau of Justice Statistics, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

[[Page 20423]]

SUMMARY:  The Department of Justice (DOJ), Office of Justice Programs, 
Bureau of Justice Statistics, will be submitting the following 
information collection request to the Office of Management and Budget 
(OMB) for review and approval in accordance with the Paperwork 
Reduction Act of 1995. This proposed information collection was 
previously published in the Federal Register at 81 FR 6050, February 4, 
2016, allowing for a 60 day comment period.

DATES:  Comments are encouraged and will be accepted for an additional 
30 days until May 9, 2016.

FOR FURTHER INFORMATION CONTACT: If you have additional comments 
especially on the estimated public burden or associated response time, 
suggestions, or need a copy of the proposed information collection 
instrument with instructions or additional information, please contact 
Jennifer Truman or Rachel Morgan, Statisticians, Bureau of Justice 
Statistics, 810 Seventh Street NW., Washington, DC 20531 (email: 
Jennifer.Truman@usdoj.gov; telephone: 202-514-5083; email: 
Rachel.Morgan@usdoj.gov; telephone: 202-616-1707). Written comments 
and/or suggestions can also be directed to the Office of Management and 
Budget, Office of Information and Regulatory Affairs, Attention 
Department of Justice Desk Officer, Washington, DC 20530 or sent to 
OIRA_submissions@omb.eop.gov.

SUPPLEMENTARY INFORMATION:  Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:
--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the Bureau of Justice 
Statistics, including whether the information will have practical 
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.
    Overview of this information collection:
    (1) Type of Information Collection: Reinstatement of the 
Supplemental Victimization Survey (SVS), with changes, a previously 
approved collection for which approval has expired.
    (2) Title of the Form/Collection: 2016 Supplemental Victimization 
Survey (SVS)
    (3) Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: The form number for 
the questionnaire is SVS-1. The applicable component within the 
Department of Justice is the Bureau of Justice Statistics, in the 
Office of Justice Programs.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract: Respondents will be persons 16 years or older 
living in households located throughout the United States sampled for 
the National Crime Victimization Survey (NCVS). The SVS will be 
conducted as a supplement to the NCVS in all sample households for a 
six (6) month period. The SVS is primarily an effort to measure the 
prevalence of stalking victimization among persons, the types of 
stalking victimization experienced, the characteristics of stalking 
victims, the nature and consequences of stalking victimization, and 
patterns of reporting to the police. BJS plans to publish this 
information in reports and reference it when responding to queries from 
the U.S. Congress, Executive Office of the President, the U.S. Supreme 
Court, state officials, international organizations, researchers, 
students, the media, and others interested in criminal justices 
statistics.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: An estimate of 
the total number of respondents is 111,960. About 98.5% (110,280) will 
have no stalking victimization and will complete the short interview 
with an average burden of four (4) minutes. Among the 1.5% of 
respondents (1,679) who experience stalking victimization, the time to 
ask the detailed questions regarding the aspects of their stalking 
victimization is estimated to take an average of 12.25 minutes. 
Respondents will be asked to respond to this survey only once during 
the six month period. The burden estimates are based on data from the 
prior administration of the SVS.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: There are an estimated 8,055 total burden hours 
associated with this collection.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., 3E.405B, Washington, DC 20530.

    Dated: April 4, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-07961 Filed 4-6-16; 8:45 am]
 BILLING CODE 4410-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.